Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALTECH BATTERIES LTD AGM Information 2016

Oct 10, 2016

64444_rns_2016-10-10_f681673b-b2e5-48cf-a9b0-fcf39ea5d242.pdf

AGM Information

Open in viewer

Opens in your device viewer

ALTECH CHEMICALS LIMITED ACN 125 301 206

NOTICE OF ANNUAL GENERAL MEETING

TIME : 11:00am (WST) DATE : Friday 11 November 2016 PLACE : Altech Chemicals Limited Suite 8 295 Rokeby Road Subiaco WA 6008

This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the Company Secretary, Shane Volk, on +61 8 6168 1555.

CONTENTS PAGE

Business of the Meeting (setting out the proposed resolutions) 3
Explanatory Statement (explaining the proposed resolutions) 5
Glossary 16
Proxy Form 18
IMPORTANT INFORMATION

TIME AND PLACE OF MEETING

Notice is given that the Annual General Meeting of the Shareholders to which this Notice of Meeting relates will be held at 11:00am (WST) on Friday 11 November 2016 at:

Suite 8, 295 Rokeby Road, Subiaco, WA 6008.

YOUR VOTE IS IMPORTANT

The business of the Annual General Meeting affects your shareholding and your vote is important.

VOTING ELIGIBILITY

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Annual General Meeting are those who are registered Shareholders at 5:00pm (WST) on Wednesday 9 November 2016.

VOTING IN PERSON

To vote in person, attend the Annual General Meeting at the time, date and place set out above.

VOTING BY PROXY

To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, members are advised that:

  • each member has a right to appoint a proxy;

  • the proxy need not be a member of the Company; and

  • a member who is entitled to cast 2 or more votes may appoint 2 proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints 2 proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

Shareholders and their proxies should be aware that changes to the Corporations Act made in 2011 mean that:

  • if proxy holders vote, they must cast all directed proxies as directed; and

  • any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.

1

Further details on these changes is set out below.

Proxy vote if appointment specifies way to vote

Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular resolution and, if it does :

  • the proxy need not vote on a show of hands, but if the proxy does so, the proxy must vote that way (i.e. as directed); and

  • if the proxy has 2 or more appointments that specify different ways to vote on the resolution – the proxy must not vote on a show of hands; and

  • if the proxy is the chair of the meeting at which the resolution is voted on – the proxy must vote on a poll, and must vote that way (i.e. as directed); and

  • if the proxy is not the chair – the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (i.e. as directed).

Transfer of non-chair proxy to chair in certain circumstances

Section 250BC of the Corporations Act provides that, if:

  • an appointment of a proxy specifies the way the proxy is to vote on a particular resolution at a meeting of the Company's members; and

  • the appointed proxy is not the chair of the meeting; and

  • at the meeting, a poll is duly demanded on the resolution; and

  • either of the following applies:

  • the proxy is not recorded as attending the meeting;

  • the proxy does not vote on the resolution,

the chair of the meeting is taken, before voting on the resolution closes, to have been appointed as the proxy for the purposes of voting on the resolution at the meeting.

2

BUSINESS OF THE MEETING

AGENDA

ORDINARY BUSINESS

1. FINANCIAL STATEMENTS AND REPORTS

To receive and consider the annual financial report of the Company for the financial year ended 30 June 2016 together with the declaration of the directors, the directors’ report, the Remuneration Report and the auditor’s report.

2. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT

To consider and, if thought fit, to pass, with or without amendment, the following resolution as a nonbinding resolution :

“That, for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as contained in the Company’s annual financial report for the financial year ended 30 June 2016 .”

Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.

Voting Prohibition Statement:

A vote on this Resolution must not be cast (in any capacity) by or on behalf of any of the following persons:

  • (a) a member of the Key Management Personnel, details of whose remuneration are included in the Remuneration Report; or

  • (b) a Closely Related Party of such a member.

However, a person (the voter ) described above may cast a vote on this Resolution as a proxy if the vote is not cast on behalf of a person described above and either:

  • (a) the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this Resolution; or

  • (b) the voter is the Chair and the appointment of the Chair as proxy:

  • (i) does not specify the way the proxy is to vote on this Resolution; and

  • (ii) expressly authorises the Chair to exercise the proxy even though this Resolution is connected directly or indirectly with the remuneration of a member of the Key Management Personnel for the Company, or if the Company is part of a consolidated entity, for the entity.

3. RESOLUTION 2 – APPROVAL OF 10% PLACEMENT CAPACITY

To consider and, if thought fit, to pass, with or without amendment, the following resolution as a special resolution :

“That, for the purpose of ASX Listing Rule 7.1A and for all other purposes, approval is given for the issue of Equity Securities totalling up to 10% of the issued capital of the Company at the time of issue, calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Statement.”

Short Explanation: Approval is being sought for the Company to issue new shares of up to 10% of its total shares on issue 12 months prior to the proposed new share issue under ASX Listing Rule 7.1A, which is additional to the 15% annual placement capacity that is available to the Company under ASX Listing Rule 7.1. This will provide the Company with flexibility to raise capital during the next 12 months over and above the 15% placement capacity.

3

Voting Exclusion : The Company will disregard any votes cast on this Resolution by any person who may participate in the issue of Equity Securities under this Resolution and a person who might obtain a benefit, except a benefit solely in the capacity of a holder of ordinary securities, if the Resolution is passed and any associates of those persons. However, the Company will not disregard a vote if it is cast by a person as a proxy for a person who is entitled to vote, in accordance with the directions on the Proxy Form, or, it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the Proxy Form to vote as the proxy decides.

4. RESOLUTION 3 – RE-ELECTION OF DIRECTOR – MR PETER BAILEY

Under the Company’s constitution one third of Directors must retire at the Company’s Annual General Meeting. Mr Bailey is therefore retiring and seeking re-election.

The Company is seeking the re-election of Mr Bailey due to his 40 plus years’ experience in the mining and industrial chemical production industry. Mr Bailey spent the majority of his career in the alumina chemicals and alumina refining industries. Accordingly, the Company proposes that Shareholders consider and, if thought fit, pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purpose of clause 13.2 of the Constitution, ASX Listing Rule 14.4 and for all other purposes, Peter Bailey, a Director, retires by rotation, and being eligible, is re-elected as a Director.”

Short Explanation: Mr Peter Bailey retires as a director of the Company, and being eligible seeks reelection as a director of the Company under this Resolution.

5. RESOLUTION 4 – RE-ELECTION OF DIRECTOR – MR DAN TENARDI

Under the Company’s constitution one third of Directors must retire at the Company’s Annual General Meeting. Mr Tenardi is therefore retiring and seeking re-election.

The Company is seeking the re-election of Mr Tenardi due to his extensive experience as a global resource executive in the mining and minerals processing sectors, including the Alumina industry and believe he is a valuable asset to the Board. Accordingly, the Company proposes that Shareholders consider and, if thought fit, pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purpose of clause 13.2 of the Constitution, ASX Listing Rule 14.4 and for all other purposes, Dan Tenardi, a Director, retires by rotation, and being eligible, is re-elected as a Director.”

Short Explanation: Mr Dan Tenardi retires as a director of the Company, and being eligible seeks reelection as a director of the Company under this Resolution.

BY ORDER OF THE BOARD

==> picture [78 x 46] intentionally omitted <==

SHANE VOLK COMPANY SECRETARY ALTECH CHEMICALS LIMITED

10 OCTOBER 2016

4

EXPLANATORY STATEMENT

This Explanatory Statement has been prepared to provide information that the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions which are the subject of the business of the Meeting.

1. ACTION TO BE TAKEN BY SHARHEOLDERS

Shareholders should read the Notice and this Explanatory Memorandum carefully before deciding how to vote on the Resolutions.

1.1 Proxies

A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to appoint a representative (a 'proxy') to vote in their place. All Shareholders are invited and encouraged to attend the Meeting or, if they are unable to attend in person, sign and return the Proxy Form to the Company in accordance with the instructions thereon. Lodgement of a Proxy Form will not preclude a Shareholder from attending and voting at the Meeting in person.

Please note that:

  • (a) a member of the Company entitled to attend and vote at the Annual General Meeting is entitled to appoint a proxy;

  • (b) a proxy need not be a member of the Company; and

  • (c) a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise, but where the proportion or number is not specified, each proxy may exercise half of the votes.

The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy Forms.

2. FINANCIAL STATEMENTS AND REPORTS

In accordance with section 317 of the Corporations Act and the Constitution, the business of the Meeting will include receipt and consideration of the annual financial report of the Company for the financial year ended 30 June 2016 together with the declaration of the directors, the directors’ report, the Remuneration Report and the auditor’s report.

The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless specifically requested to do so. The Company’s annual financial report is available on its website at http://www.altechchemicals.com.

3. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT

3.1 General

The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory only and does not bind the company or the directors of the company.

The remuneration report sets out the company’s remuneration arrangements for the directors and senior management of the company. The remuneration report is part of the directors’ report contained in the annual financial report of the company for a financial year.

The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or make comments on the remuneration report at the annual general meeting.

5

3.2 Voting consequences

Under changes to the Corporations Act which came into effect on 1 July 2011, a company is required to put to its shareholders a resolution proposing the calling of another meeting of shareholders to consider the appointment of directors of the company ( Spill Resolution ) if, at consecutive annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general meetings.

If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder meeting ( Spill Meeting ) within 90 days of the second annual general meeting.

All of the directors of the company who were in office when the directors' report (as included in the company’s annual financial report for the most recent financial year) was approved, other than the managing director of the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election at the Spill Meeting.

Following the Spill Meeting those persons whose election or re-election as directors of the company is approved will be the directors of the company.

3.3 Previous voting results

At the Company’s previous annual general meeting the votes cast against the remuneration report considered at that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not relevant for this Annual General Meeting.

3.4 Proxy voting restrictions

Shareholders appointing a proxy for this Resolution should note the following:

Proxy Directions given No directions given
Key Management Personnel1 Vote as directed Unable to vote3
Chair2 Vote as directed Able to vote at discretion of Proxy4
Other Vote as directed Able to vote at discretion of Proxy

Notes:

1 Refers to Key Management Personnel (other than the Chair) whose remuneration details are included in the Remuneration Report, or a Closely Related Party of such a member.

2 Refers to the Chair (where he/she is also a member of the Key Management Personnel whose remuneration details are included in the Remuneration Report), or a Closely Related Party of such a member).

3 Undirected proxies granted to these persons will not be voted and will not be counted in calculating the required majority if a poll is called on this Resolution.

4 The Proxy Form notes it is the Chair’s intention to vote all undirected proxies in favour of all Resolutions.

6

4. RESOLUTION 2 – APPROVAL OF 10% PLACEMENT CAPACITY

4.1 General

ASX Listing Rule 7.1A provides that an Eligible Entity may seek Shareholder approval at its annual general meeting to allow it to issue Equity Securities up to 10% of its issued capital ( 10% Placement Capacity ).

The Company is an Eligible Entity.

If Shareholders approve Resolution 2, the number of Equity Securities the Eligible Entity may issue under the 10% Placement Capacity will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (as set out in Section 4.2 below).

The effect of Resolution 2 will be to allow the Directors to issue Equity Securities up to 10% of the Company’s fully paid ordinary securities on issue under the 10% Placement Capacity during the period up to 12 months after the Meeting, without subsequent Shareholder approval and without using the Company’s 15% annual placement capacity granted under ASX Listing Rule 7.1.

Resolution 2 is a special resolution. Accordingly, at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting must be in favour of Resolution 2 for it to be passed.

4.2 ASX Listing Rule 7.1A

ASX Listing Rule 7.1A came into effect on 1 August 2012 and enables an Eligible Entity to seek shareholder approval at its annual general meeting to issue Equity Securities in addition to those under the Eligible Entity’s 15% annual placement capacity.

An Eligible Entity is one that, as at the date of the relevant annual general meeting:

  • (a) is not included in the S&P/ASX 300 Index; and

  • (b) has a maximum market capitalisation (excluding restricted securities and securities quoted on a deferred settlement basis) of $300,000,000.

As at the date of this Notice, the Company is an Eligible Entity as it is not included in the S&P/ASX 300 Index and has a current market capitalisation of approximately $29,280,714 (based on the number of Shares on issue and the closing price of $0.11).

Any Equity Securities issued must be in the same class as an existing class of quoted Equity Securities. The Company currently has one class of quoted Equity Securities on issue, being the Shares.

The exact number of Equity Securities that the Company may issue under an approval under ASX Listing Rule 7.1A will be calculated according to the following formula:

(A x D) – E

Where:

A is the number of Shares on issue 12 months before the date of issue or agreement:

  • (a) plus the number of Shares issued in the previous 12 months under an exception in ASX Listing Rule 7.2;

  • (b) plus the number of partly paid shares that became fully paid in the previous 12 months;

  • (c) plus the number of Shares issued in the previous 12 months with approval of holders of Shares under ASX Listing Rules 7.1 and 7.4. This does not include an issue of fully paid ordinary shares under the entity’s 15% placement capacity without shareholder approval; and

7

  • (d) less the number of Shares cancelled in the previous 12 months.

  • D is 10%.

E is the number of Equity Securities issued or agreed to be issued under ASX Listing Rule 7.1A.2 in the 12 months before the date of issue or agreement to issue that are not issued with the approval of holders of Ordinary Securities under ASX Listing Rule 7.1 or 7.4.

The ability of an entity to issue Equity Securities under Listing Rule 7.1A is in addition to the entity's 15% placement capacity under Listing Rule 7.1. At the date of this Notice, the Company has on issue 266,188,312 Shares and has a capacity to issue:

  • (i) 39,711,839 Equity Securities under Listing Rule 7.1; and

  • (ii) 26,600,013 Equity Securities under Listing Rule 7.1A.

The actual number of Equity Securities that the Company will have capacity to issue under Listing Rule 7.1A will be calculated at the date of issue of the Equity Securities in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer to Section 7.1 (c) above).

4.3 Technical information required by ASX Listing Rule 7.1A

Pursuant to and in accordance with ASX Listing Rule 7.3A, the information below is provided in relation to this Resolution 2:

(a) Minimum Price

The minimum price at which the Equity Securities may be issued is 75% of the volume weighted average price of Equity Securities in that class, calculated over the 15 ASX trading days on which trades in that class were recorded immediately before:

  • (i) the date on which the price at which the Equity Securities are to be issued is agreed; or

  • (ii) if the Equity Securities are not issued within 5 (five) ASX trading days of the date in paragraph 4.3(a)(i), the date on which the Equity Securities are issued.

(b) Date of Issue

The Equity Securities may be issued under the 10% Placement Capacity commencing on the date of the Meeting and expiring on the first to occur of the following:

  • (i) 12 months after the date of this Meeting; and

  • (ii) the date of approval by Shareholders of any transaction under ASX Listing Rules 11.1.2 (a significant change to the nature or scale of the Company’s activities) or 11.2 (disposal of the Company’s main undertaking) (after which date, an approval under ASX Listing Rule 7.1A ceases to be valid),

( 10% Placement Capacity Period ).

(c) Risk of voting dilution

Any issue of Equity Securities under the 10% Placement Capacity will dilute the interests of Shareholders who do not receive any Shares under the issue.

If Resolution 2 is approved by Shareholders and the Company issues the maximum number of Equity Securities available under the 10% Placement Capacity, the economic and voting dilution of existing Shares would be as shown in the table below.

The table below shows the dilution of existing Shareholders calculated in accordance with the formula outlined in ASX Listing Rule 7.1A(2), on the basis of the current market price of Shares and the current number of Equity Securities on issue as at the date of this Notice.

8

The table also shows the voting dilution impact where the number of Shares on issue (Variable A in the formula) changes and the economic dilution where there are changes in the issue price of Shares issued under the 10% Placement Capacity.

Number of Shares
on Issue
(Variable “A” in
Listing Rule 7.1A2
Dilution
Issue Price (per
Share)
$0.055 $0.11 $0.22
(50%
decrease in
current
issue
price)
(Current
issue price)
(100%
increase in
current
issue price)
266,188,312 Shares issued – 10%
voting dilution
26,618,831 26,618,831 26,618,831
(Current Variable A) Funds Raised $1,464,036 $2,928,071 $5,856,142
399,282,468 Shares issued – 10%
voting dilution
39,928,247 39,928,247 39,928,247
(50% increase in
*Variable A) **
Funds Raised $2,196,054 $4,392,107 $8,784,214
532,376,624 Shares issued– 10%
voting dilution
53,237,662 53,237,662 53,237,662
(100% increase in
*Variable A) **
Funds Raised $2,928,071 $5,856,143 $11,712,857
  • The number of Shares on issue (Variable A in the formula) could increase as a result of the issue of

  • Shares that do not require Shareholder approval (such as under a pro-rata rights issue or scrip issued under a takeover offer) or that are issued with Shareholder approval under ASX Listing Rule 7.1.

The table above uses the following assumptions:

  1. There are currently 266,188,312 Shares on issue.

  2. No Options are exercised before the date of the issue of the Equity Securities

  3. No Employee Performance Rights, vest and convert to Shares before the date of the issue of the Equity Securities.

  4. The issue price set out above is the closing price of the Shares on the ASX on 7 October 2016.

  5. The Company issues the maximum possible number of Equity Securities under the 10% Placement Capacity.

  6. The Company has issued Shares in the previous 12 months. The Company has not issued any other Equity Securities in the 12 months prior to the Meeting that were not issued under an exception in ASX Listing Rule 7.2 or with approval under ASX Listing Rule 7.1. or 7.1A.

  7. The issue of Equity Securities under the 10% Placement Capacity consists only of Shares. If the issue of Equity Securities includes quoted Options, it is assumed that those quoted Options are exercised into Shares for the purpose of calculating the voting dilution effect on existing Shareholders.

  8. The calculations above do not show the dilution that any one particular Shareholder will be subject to. All Shareholders should consider the dilution caused to their own shareholding depending on their specific circumstances.

  9. This table does not set out any dilution pursuant to approvals under ASX Listing Rule 7.1.

  10. The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital at the time of issue. This is why the voting dilution is shown in each example as 10%.

  11. The table does not show an example of dilution that may be caused to a particular Shareholder by reason of placements under the 10% Placement Capacity, based on that Shareholder’s holding at the date of the Meeting.

9

Shareholders should note that there is a risk that:

  • (i) the market price for the Company’s Shares may be significantly lower on the issue date than on the date of the Meeting; and

  • (ii) the Shares may be issued at a price that is at a discount to the market price for those Shares on the date of issue.

(d) Purpose of Issue under 10% Placement Capacity

The Company may issue Equity Securities under the 10% Placement Capacity for the following purposes:

  • (i) as cash consideration in which case the Company intends to use funds raised for the continued development of the Company’s High Purity Alumina Project, acquisition of new resources, assets and investments (including expenses associated with such an acquisition) and general working capital; or

  • (ii) as non-cash consideration for the acquisition of new resources assets and investments, in such circumstances the Company will provide a valuation of the non-cash consideration as required by listing Rule 7.1A.3.

The Company will comply with the disclosure obligations under ASX Listing Rules 7.1A(4) and 3.10.5A upon issue of any Equity Securities.

(e) Allocation under the 10% Placement Capacity

The Company’s allocation policy for the issue of Equity Securities under the 10% Placement Capacity will be dependent on the prevailing market conditions at the time of the proposed placement(s).

The recipients of the Equity Securities to be issued under the 10% Placement Capacity have not yet been determined. However, the recipients of Equity Securities could consist of current Shareholders or new investors (or both), none of whom will be related parties of the Company. The Company will determine the recipients at the time of the issue under the 10% Placement Capacity, having regard to the following factors:

  • (i) the purpose of the issue;

  • (ii) alternative methods for raising funds available to the Company at that time, including, but not limited to, an entitlement issue or other offer where existing Shareholders may participate;

  • (iii) the effect of the issue of the Equity Securities on the control of the Company;

  • (iv) the circumstances of the Company, including, but not limited to, the financial position and solvency of the Company;

  • (v) prevailing market conditions; and

  • (vi) advice from corporate, financial and broking advisers (if applicable).

Further, if the Company is successful in acquiring new resources, assets or investments, it is likely that the recipients under the 10% Placement Capacity will be vendors of the new resources, assets or investments.

(f) Previous Approval under ASX Listing Rule 7.1A

The Company previously obtained approval from its Shareholders under ASX Listing Rule 7.1A at its annual general meeting held on 15 October 2015 ( Previous Approval ).

The Company has issued 17,978,173 Shares pursuant to the Previous Approval.

10

The Company has issued (net of converting securities) a total of 95,044,346 additional Equity Securities during the 12 months preceding the date of the Meeting, being on and from 12 November 2015. The total Equity Securities issued during the 12 months preceding the date of the Meeting (net of converting securities) represents approximately 53.96% of the total diluted number of Equity Securities on issue in the Company on 12 November 2015, which were 177,816,355.

Information relating to issues of Equity Securities by the Company in the 12 months prior to the date of this Meeting is as follows:

Date Recipients Equity
Security
Price (and discount
to market if any)
Key terms Amount Raised Use of
Funds or non-cash
Consideration
3-Dec-2015 to
18-Dec-2015
3B’s 3-Dec-
2015, 17-Dec-
2015 & 18-
Dec-2015
Various
existing
Shareholders
508,582 fully
paid ordinary
shares

$0.10 per share,
being the exercise
price of the listed
options
Exercise of quoted options
(Ex price $0.10, expiry 15-
Dec-2015)
Cash: $50,858
Funds were used to
commence detailed
design of the
Company’s proposed
Malaysian high purity
alumina (HPA) plant, for
corporate costs and
general working capital
purposes.
5-Jan-2016
Appendix 3B–
6-Jan-2016
Employees of
the Company
1,950,000
fully paid
ordinary
shares
Nil cash
consideration
(Satisfaction of
performance
hurdles)
Employee Performance
Rights were issued to
employees under the
Employee Performance
Rights Plan approved by
Shareholders at the Annual
General Meeting held 5
November 2014.
The Performance Rights
converted to Shares upon
vesting conditions being
satisfied.
Non-Cash
Consideration -
Performance based
remuneration for
services provided to the
Company.
No funds raised, fair
value calculated at time
was $153,900.
Value of the converted
shares at the time of
this notice is
approximately
$212,856.
1-Feb-2016
Appendix 3B–
1-Feb-2016
Employees of
the Company
200,000
Performance
Rights1
Nil cash
consideration
(Performance
based
remuneration)
Employee Performance
Rights were issued to
employees under the
Employee Performance
Rights Plan approved by
Shareholders at the Annual
General Meeting held 5
November 2014.
Non-Cash
Consideration -
Performance based
remuneration
Value of the
Performance Rights at
the date of issue
$14,750 and at the time
of this notice is
approximately $23,400
2-Mar-2016
Appendix 3B–
2-Mar-2016
Employees of
the Company
200,000
Performance
Rights1
Nil cash
consideration
(Performance
based
remuneration)
Employee Performance
Rights were issued to
employees under the
Employee Performance
Rights Plan approved by
Shareholders at the Annual
General Meeting held 5
November 2014.
Non-Cash
Consideration -
Performance based
remuneration
Value of the
Performance Rights at
the date of issue
$14,750 and at the time
of this notice is
approximately $23,400

11

Date Recipients Equity
Security
Price (and discount
to market if any)
Key terms Amount Raised Use of
Funds or non-cash
Consideration
18-Mar-2016
Appendix 3B–
18-Mar-2016
Various non-
executive
directors of
the Company
1,750,000
fully paid
ordinary
shares
Nil cash
consideration
(Satisfaction of
performance
hurdles)
Director Performance Rights
were issued under the
Employee Performance
Rights Plan approved by
Shareholders at the Annual
General Meeting held 5
November 2014.
The Performance Rights
converted to Shares upon
vesting conditions being
satisfied.
Non-Cash
Consideration -
Performance based
remuneration for
services provided to the
Company.
No funds raised, fair
value calculated at time
was $176,696.
Value of the converted
shares at the time of
this notice is
approximately $61.250.
5-April-2016
Appendix 3B–
5-April-2016
Various
professional
and
sophisticated
investors
14,264,776
fully paid
ordinary
shares
$0.086 per share,
representing a
~14% discount to
the 5-day VWAP of
the shares as
traded on the ASX
immediately
preceding the
placement
announcement
The $1.2 million share
placement was announced
on 24 March 2016 to a
variety of professional and
sophisticated investors
Cash: $1,206,998 and
Non-cash (capital
raising fees) at fair
value of $19,773
Funds were used for
detailed design of the
Company’s proposed
Malaysian high purity
alumina (HPA) plant
and for corporate costs
and general working
capital purposes.
12-April-2016
Appendix 3B–
12-April-2016
Various
existing
shareholders
of the
Company
8,651,175
fully paid
ordinary
shares
$0.086 per share
per share,
representing a
~14% discount to
the 5-day VWAP of
the shares as
traded on the ASX
immediately
preceding the share
purchase plan
announcement
Existing shareholder of the
Company were able to
subscribe to a maximum of
$15,000 of new shares at
$0.086 per share, pursuant
to the Share Purchase Plan
(SPP) rules.
Cash: $744,001
Funds were used for
detailed design of the
Company’s proposed
Malaysian high purity
alumina (HPA) plant
and for corporate costs
and general working
capital purposes.
9-June-2016
to
27 June 2016
Appendix 3B–
9-June-2016,
13 June 2016
and
27 June 2016



Various option
holders
2,500,000
fully paid
ordinary
shares
$0.10 per share,
being the exercise
price of the unlisted
listed options
Exercise of unlisted options
(Ex price $0.10, expiry 30-
June-2016)
Cash: $250,000
Funds were used for
detailed design of the
Company’s proposed
Malaysian high purity
alumina (HPA) plant
and for corporate costs
and general working
capital purposes.

12

Date Recipients Equity
Security
Price (and discount
to market if any)
Key terms Amount Raised Use of
Funds or non-cash
Consideration
3-Aug-2016
Appendix 3B–
3-Aug-2016
Various
professional
and
sophisticated
investors
43,911,209
fully paid
ordinary
shares
$0.14 per share,
representing a
~14% discount to
the 5-day VWAP of
the shares as
traded on the ASX
immediately
preceding the
placement
announcement
The share placement was
announced on 27 July 2016
to a variety of professional
and sophisticated investors
Cash: $5,689,570 and Non-
cash (capital raising fees)
at fair value of $457,999
Funds were used for
detailed design of the
Company’s proposed
Malaysian high purity
alumina (HPA) plant and
for corporate costs and
general working capital
purposes.
4-Aug-2016
Appendix 3B–
4-Aug-2016
MAA Group
Berhad &
various
existing
sharholders
11,744,176
fully paid
ordinary
shares
$0.086 per share,
representing a
~14% discount to
the 5-day VWAP of
the shares as
traded on the ASX
immediately
preceding the
placement
agreement
A $1.0 million share
placement at $0.086 per
share to Malaysian public
company MAA Group
Berhad, a related party to
Altech non-executive director
Tunku Yaacob Khyra

Cash: $1,010,000
Funds will be used for
finalising detailed design of
the Company’s proposed
Malaysian high purity
alumina (HPA) plant,
completion of independent
due diligence associated
with finalising debt
financing, closure of debt
financing and for general
working capital purposes.2
4-Aug-2016
Appendix 3B–
4-Aug-2016
Non-executive
director and
alternate
director
3,000,000
Performance
Rights1
Nil cash
consideration
(Performance
based
remuneration)
The Performance Rights
were issued to a non-
executive director, an
alternate director and an
employee, pursuant to the
Company Employee
Performance Rights Plan.
The issue of the Rights to
directors was approved by
shareholders in general
meeting on 29 July 2016
Non-Cash
Consideration -
Performance based
remuneration for services
provided to the Company
Value of the Performance
Rights at the date of issue
$396,000 and at the time
of this notice is
approximately $343,200
7-Sept-2016
Appendix 3B–
7-Sept-2016
Employees of
the Company
400,000
Performance
Rights1
Nil cash
consideration
(Performance
based
remuneration)
Employee Performance
Rights were issued to
employees under the
Employee Performance
Rights Plan approved by
Shareholders at the Annual
General Meeting held 5
November 2014.
Non-Cash
Consideration -
Performance based
remuneration
Value of the Performance
Rights at the date of issue
$48,600 and at the time of
this notice is
approximately $46,800
21-Sept-2016
Appendix 3B-
21-Sept-2016
Various
professional
and
sophisticated
investors
30,751,183
fully paid
ordinary
shares
$0.14 per share,
representing a
~14% discount to
the 5-day VWAP of
the shares as
traded on the ASX
immediately
preceding the
placement
announcement
The share placement was
announced on 27 July 2016
to a variety of professional
and sophisticated investors.
Shareholder approval for
the placement was received
16 September 2016
Cash: $4,305,166
Funds will be used for
finalising detailed design of
the Company’s proposed
Malaysian high purity
alumina (HPA) plant,
completion of independent
due diligence associated
with finalising debt
financing, closure of debt
financing and for general
working capital purposes.2

13

Notes:

1. Performance Rights convertible to Shares upon attainment of pre-defined performance hurdles in accordance with the terms and conditions of the Company Performance Rights Plan, pursuant to Shareholder approval received at the Company’s annual general meeting held on 5 November 2014.

2. This is a statement of current intentions as at the date of this Notice. As with any budget, intervening events and new circumstances have the potential to affect the manner in which the funds are ultimately applied. The Board reserves the right to alter the way the funds are applied on this basis.

(g) Compliance with ASX Listing Rules 7.1A.4 and 3.10.5A

When the Company issues Equity Securities pursuant to the 10% Placement Capacity, it will give to ASX:

(i) a list of the recipients of the Equity Securities and the number of Equity Securities issued to each (not for release to the market), in accordance with Listing Rule 7.1A.4; and

(ii) the information required by Listing Rule 3.10.5A for release to the market.

4.4 Voting Exclusion

A voting exclusion statement is included in this Notice.

As at the date of this Notice, the Company has not invited any existing Shareholder to participate in an issue of Equity Securities under ASX Listing Rule 7.1A. Therefore, no existing Shareholders will be excluded from voting on Resolution 2.

5. RESOLUTION 3 & 4 – RE-ELECTION OF DIRECTORS – PETER BAILEY & DAN TENARDI

ASX Listing Rule 14.4 provides that a director of an entity must not hold office (without re-election) past the third AGM following the director’s appointment or 3 year, whichever is the longer.

Clause 13.2 of the Constitution requires that at the Company's annual general meeting in every year, one-third of the Directors for the time being, or, if their number is not a multiple of 3, then the number nearest one-third (rounded upwards in case of doubt), shall retire from office, provided always that no Director (except a Managing Director) shall hold office for a period in excess of 3 years, or until the third annual general meeting following his or her appointment, whichever is the longer, without submitting himself or herself for re-election.

The Directors to retire at an annual general meeting are those who have been longest in office since their last election, but, as between persons who became Directors on the same day, those to retire shall (unless they otherwise agree among themselves) be determined by drawing lots.

A Director who retires by rotation under clause 13.2 of the Constitution is eligible for re-election.

The Company currently has 5 Directors and accordingly, 2 must retire.

Messrs Peter Bailey and Dan Tenardi will retire in accordance with clause 13.2 of the Constitution and, being eligible, seek re-election.

Peter Bailey

Mr Bailey is a highly experienced and qualified engineer with over 40 years’ experience in the mining and industrial chemical production industries. Mr Bailey spent the majority of his career in the alumina chemicals and alumina refining industries. He was previously chief executive officer at Sherwin Alumina, an alumina refinery located in Texas, USA.

14

If re-elected, the board considers Mr Bailey will be an independent director. The board supports the re-election of Mr Bailey and recommends that shareholders vote in favour of Resolution 3.

Dan Tenardi

Mr Tenardi is a highly experienced mining executive with some 40 years in the resources industry, including holding senior executive positions with a number of global resource industry leaders across a range of commodities, including iron ore, gold, bauxite and copper. Mr Tenardi previously spent 13 years with Alcoa, at its bauxite mines in the Darling Range in Western Australia, and a further two years at Alcoa’s Kwinana refinery.

If re-elected, the board does not consider Mr Tenardi will be an independent director. The board supports the re-election of Mr Tenardi and recommends that shareholders vote in favour of Resolution 4.

6. ENQUIRIES

Shareholders are requested to contact the Company Secretary, Shane Volk, on (+61 8) 6168 1555 if they have any queries in respect of the matters set out in these documents.

15

GLOSSARY

10% Placement Capacity has the meaning given in section 4.1 of the Explanatory Statement.

  • $ means Australian dollars.

Annual General Meeting or Meeting means the meeting convened by the Notice.

ASIC means the Australian Securities & Investments Commission.

ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.

ASX Listing Rules means the Listing Rules of ASX.

Board means the current board of directors of the Company.

Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.

Chair means the chair of the Meeting.

Closely Related Party of a member of the Key Management Personnel means:

  • (a) a spouse or child of the member;

  • (b) a child of the member’s spouse;

  • (c) a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

  • (e)

  • a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth ).

Company means Altech Chemicals Limited (ACN 125 301 206).

Completion Date means the date on which the Company announces to the Australian Securities Exchange the completion of its High Purity Alumina project.

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth).

Directors means the current directors of the Company.

  • Eligible Entity means an entity that, at the date of the relevant general meeting:

  • (a) is not included in the S&P/ASX 300 Index; and

  • (b) has a maximum market capitalisation (excluding restricted securities and securities quoted on a deferred settlement basis) of $300,000,000.

Equity Securities includes a Share, a right to a Share or Option, an Option, a convertible security and any security that ASX decides to classify as an Equity Security.

Explanatory Statement means the explanatory statement accompanying the Notice.

16

Key Management Personnel has the same meaning as in the accounting standards issued by the Australian Accounting Standards Board and means those persons having authority and responsibility for planning, directing and controlling the activities of the Company, or if the Company is part of a consolidated entity, of the consolidated entity, directly or indirectly, including any director (whether executive or otherwise) of the Company, or if the Company is part of a consolidated entity, of an entity within the consolidated group.

Notice or Notice of Meeting or Notice of Annual General Meeting means this notice of annual general meeting including the Explanatory Statement and the Proxy Form.

Option means an option to acquire a Share.

Ordinary Securities has the meaning set out in the ASX Listing Rules.

Proxy Form means the proxy form accompanying the Notice.

Remuneration Report means the remuneration report set out in the Director’s report section of the Company’s annual financial report for the year ended 30 June 2016.

Resolutions means the resolutions set out in the Notice of Meeting, or any one of them, as the context requires.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share.

Variable A means “A” as set out in the calculation in section 4.3 of the Explanatory Statement.

WST means Western Standard Time as observed in Perth, Western Australia.

17

APPOINTMENT OF PROXY FORM

ALTECH CHEMICALS LIMITED ACN 125 301 206

ANNUAL GENERAL MEETING

I/We

of:

being a Shareholder entitled to attend and vote at the Meeting, hereby appoint:

Name:

OR: the Chair of the Meeting as my/our proxy.

or failing the person so named or, if no person is named, the Chair, or the Chair’s nominee, to vote in accordance with the following directions, or, if no directions have been given, and subject to the relevant laws as the proxy sees fit, at the Meeting to be held at Suite 8, 295 Rokeby Road, Subiaco at 11.00am WST on 11 November 2016, and at any adjournment thereof.

AUTHORITY FOR CHAIR TO VOTE UNDIRECTED PROXIES ON REMUNERATION RELATED RESOLUTIONS

Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair to exercise my/our proxy on Resolution 1 (except where I/we have indicated a different voting intention below) even though Resolution 1 is connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.

CHAIR’S VOTING INTENTION IN RELATION TO UNDIRECTED PROXIES

The Chair intends to vote undirected proxies in favour of all Resolutions. In exceptional circumstances the Chair may change his/her voting intention on any Resolution. In the event this occurs an ASX announcement will be made immediately disclosing the reasons for the change.

Voting on business of the Meeting Voting on business of the Meeting FOR AGAINST ABSTAIN
Resolution 1 Adoption of Remuneration Report
Resolution 2 Approval of 10% Placement Capacity
Resolution 3 Re-election of Mr Peter Bailey as a director
Resolution 4 Re-election of Mr Dan Tenardi as a director

Please note : If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on a poll and your votes will not be counted in computing the required majority on a poll.

If two proxies are being appointed, the proportion of voting rights this proxy represents is: % Signature of Shareholder(s): Individual or Shareholder 1 Shareholder 2 Shareholder 3 Sole Director/Company Secretary Director Director/Company Secretary Date: Contact name: Contact ph (daytime): E-mail address: Consent for contact by e-mail: YES NO

18

Instructions for Completing ‘Appointment of Proxy’ Form

  1. ( Appointing a proxy ): A Shareholder entitled to attend and cast a vote at the Meeting is entitled to appoint a proxy to attend and vote on their behalf at the Meeting. If a Shareholder is entitled to cast 2 or more votes at the Meeting, the Shareholder may appoint a second proxy to attend and vote on their behalf at the Meeting. However, where both proxies attend the Meeting, voting may only be exercised on a poll. The appointment of a second proxy must be done on a separate copy of the Proxy Form. A Shareholder who appoints 2 proxies may specify the proportion or number of votes each proxy is appointed to exercise. If a Shareholder appoints 2 proxies and the appointments do not specify the proportion or number of the Shareholder’s votes each proxy is appointed to exercise, each proxy may exercise one-half of the votes. Any fractions of votes resulting from the application of these principles will be disregarded. A duly appointed proxy need not be a Shareholder.

  2. ( Direction to vote ): A Shareholder may direct a proxy how to vote by marking one of the boxes opposite each item of business. The direction may specify the proportion or number of votes that the proxy may exercise by writing the percentage or number of Shares next to the box marked for the relevant item of business. Where a box is not marked the proxy may vote as they choose subject to the relevant laws. Where more than one box is marked on an item the vote will be invalid on that item.

  3. ( Signing instructions ):

  4. ( Individual ): Where the holding is in one name, the Shareholder must sign.

  5. ( Joint holding ): Where the holding is in more than one name, all of the Shareholders should sign.

  6. ( Power of attorney ): If you have not already provided the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Form when you return it.

  7. ( Companies ): Where the company has a sole director who is also the sole company secretary, that person must sign. Where the company (pursuant to Section 204A of the Corporations Act) does not have a company secretary, a sole director can also sign alone. Otherwise, a director jointly with either another director or a company secretary must sign. Please sign in the appropriate place to indicate the office held. In addition, if a representative of a company is appointed pursuant to Section 250D of the Corporations Act to attend the Meeting, the documentation evidencing such appointment should be produced prior to admission to the Meeting. A form of a certificate evidencing the appointment may be obtained from the Company.

  8. ( Attending the Meeting ): Completion of a Proxy Form will not prevent individual Shareholders from attending the Meeting in person if they wish. Where a Shareholder completes and lodges a valid Proxy Form and attends the Meeting in person, then the proxy’s authority to speak and vote for that Shareholder is suspended while the Shareholder is present at the Meeting.

  9. ( Return of Proxy Form ): To vote by proxy, please complete and sign the enclosed Proxy Form and return by:

  10. (a) post to Altech Chemicals Limited, Suite 8, 295 Rokeby Road, Subiaco WA 6008 ; or

  11. (b) e-mail to the Company at shane @altechchemicals.com ; or

  12. (c) facsimile to the Company on facsimile number +61 8 6168 1551.

so that it is received not less than 48 hours prior to commencement of the Meeting.

Proxy Forms received later than this time will be invalid.

19